New research study “Psychiatry Partnering Terms and Agreements” elaborated by CurrentPartnering has been recently published by Market Publishers Ltd. May 09, 2012
The majority of psychiatry partnering deals in the biopharma industry are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors psychiatry technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Knowing the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what is expected to be achieved during the negotiation of terms...Introduction
Chapter 2 - Trends in Psychiatry Dealmaking